What does this research mean for the field?

Different classes of antihypertensive drugs have varying effects on the regression of left ventricular hypertrophy, with sympatholytics, ACE inhibitors, and calcium channel blockers inducing significant regression, whereas arteriolar vasodilators do not despite adequate blood pressure control. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to examine how different antihypertensive therapies affect left ventricular hypertrophy.

February 1, 1987HypertensionOpen Access

Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.

View Full Paper

Ask AI

Bookmark

Why the study?

Do different classes of antihypertensive drugs reduce left ventricular hypertrophy in patients with hypertension?

Population

Patients with hypertension and left ventricular hypertrophy

Design

Review

Follow-up

8 to 12 weeks

Authors

FFFetnat M. Fouad-TaraziCleveland Clinic PLPhilip R. LiebsonPreventive Cardiology

Discussion

Member takes

Implication

Antihypertensive class may modulate LVH regression beyond BP control; leaves open outcome benefits and needs prospective validation.

Key Points

This research aims to examine how different antihypertensive therapies affect left ventricular hypertrophy.
Used echocardiography to assess left ventricular wall thickness and mass reduction.
Evaluated regression after 8 to 12 weeks of therapy using various drug classes.
Compared effects of sympatholytics, converting enzyme inhibitors, calcium blockers, diuretics, and beta-blockers.
Regression of left ventricular hypertrophy observed following therapy with sympatholytics and converting enzyme inhibitors.
Calcium entry blockers showed significant hypertrophy regression; however, arteriolar vasodilators did not.
Controversial results were noted for diuretics and beta-blockers concerning their efficacy.

Structured PICO

Do different classes of antihypertensive drugs reduce left ventricular hypertrophy in patients with hypertension?

Population

Patients with hypertension and left ventricular hypertrophy

Intervention

Antihypertensive therapy including sympatholytics (methyldopa, reserpine), converting enzyme inhibitors (captopril, enalapril), calcium entry blockers, arteriolar vasodilators (hydralazine, trimazosin, minoxidil), diuretics, and beta-blockers

Outcome

Regression of left ventricular hypertrophy (reduction of left ventricular mass) assessed by echocardiographysurrogate

Different classes of antihypertensive drugs have varying effects on the regression of left ventricular hypertrophy, indicating that factors beyond blood pressure control modulate structural heart changes.

Cite This Study

Fouad-Tarazi et al. (1987) studied this question.

synapsesocial.com/papers/6a1bcfaffc87fd06169cda73 https://doi.org/10.1161/01.hyp.9.2_pt_2.ii65

Topics

Echocardiography

View Full Paper

Ask AI

Bookmark